Recent Updates — MMEDV

MiniMed Group completed its previously announced exchange offer to separate from Medtronic plc, marking its first day as a fully independent company. The transaction involved the issuance of 252,813,348 newly issued shares of MiniMed common stock in exchange for 55,032,401 Medtronic ordinary shares accepted from shareholders. As a result, Medtronic no longer holds an equity stake in MiniMed, and four directors—Linnea Burman, Scott Cundy, Laura Mauri, and Matthew R. Walter—resigned from the Board. The Board reduced its size from 11 to eight members and appointed Amy Bricker as a new director effective October 15, 2026. MiniMed is a global leader in insulin delivery systems, continuous glucose monitors, and diabetes care technologies.